About
AUBAGIO®, a once-daily pill proven to treat relapsing MS.
Sanofi Genzyme is the specialty care global business unit of Sanofi. We focus on rare diseases, multiple sclerosis, oncology, and immunology.
We help people with debilitating and complex conditions that are often difficult to diagnose and treat. Our approach is shaped by our experience developing highly specialized treatments and forging close relationships with physician and patient communities.
We are dedicated to discovering and advancing new therapies, providing hope to patients and their families around the world.
